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Abstract
Background:  During apoptosis, Ca2+-dependent events participate in the regulation of
intracellular and morphological changes including phosphatidylserine exposure in the exoplasmic
leaflet of the cell plasma membrane. The occurrence of phosphatidylserine at the surface of
specialized cells, such as platelets, is also essential for the assembly of the enzyme complexes of the
blood coagulation cascade, as demonstrated by hemorrhages in Scott syndrome, an extremely rare
genetic deficiency of phosphatidylserine externalization, without other apparent pathophysiologic
consequences. We have recently reported a reduced capacitative Ca2+ entry in Scott cells which
may be part of the Scott phenotype.
Results: Taking advantage of these mutant lymphoblastoid B cells, we have studied the relationship
between this mode of Ca2+ entry and phosphatidylserine redistribution during apoptosis. Ca2+
ionophore induced apoptosis in Scott but not in control cells. However, inhibition of store-
operated Ca2+ channels led to caspase-independent DNA fragmentation and decrease of
mitochondrial membrane potential in both control and Scott cells. Inhibition of cytochrome P450
also reduced capacitative Ca2+ entry and induced apoptosis at comparable extents in control and
Scott cells. During the apoptotic process, both control and more markedly Scott cells externalized
phosphatidylserine, but in the latter, this membrane feature was however dissociated from several
other intracellular changes.
Conclusions:  The present results suggest that different mechanisms account for
phosphatidylserine transmembrane migration in cells undergoing stimulation and programmed
death. These observations testify to the plasticity of the plasma membrane remodeling process,
allowing normal apoptosis even when less fundamental functions are defective.
Background
During apoptosis, changes in cytosolic Ca2+ are likely to
play a critical role by triggering the activation of Ca2+-de-
pendent events inducing global intracellular and mor-
phological modifications [1,2]. Among these changes,
early transverse redistribution of plasma membrane
phosphatidylserine is one of the well-documented hall-
marks of cells undergoing apoptosis [3,4], and has been
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shown to depend on caspase-3 protease activity [5] and
cytoplasmic Ca2+ concentration [6,7]. The resulting ex-
posure of phosphatidylserine in the outer leaflet may
serve as a recognition signal for phagocytosis of senes-
cent cells to be rapidly cleared [3,8–10]. Phosphatidyl-
serine is also essential for the assembly of the blood
coagulation enzyme complexes at the surface of stimu-
lated specialized cells such as platelets, as demonstrated
by hemorrhages in Scott syndrome, an extremely rare in-
herited bleeding disorder transmitted as an autosomal
recessive trait [11–13]. Blood cells from these patients
show a defective membrane-associated procoagulant ac-
tivity due to a decreased ability of phosphatidylserine ex-
ternalization after stimulation [11,12], suggesting that
Scott phenotype results from the deletion or mutation of
a regulatory element involved in this lipid transverse
transport [12,14]. Whether phosphatidylserine trans-
membrane migration is governed by common mecha-
nism(s) in apoptotic cells or stimulated platelets remains
uncertain. Last results suggest that apoptosis and proco-
agulant stimulation operate through different pathways
to activate phosphatidylserine externalization mediated
by a common molecular entity [15].
In non-excitable cells, one of the pathways for the regu-
lation of intracellular Ca2+ concentration involves store-
operated Ca2+ influx (also referred to as capacitative
Ca2+ entry). Activation of voltage-independent Ca2+
channels after sustained depletion of intracellular Ca2+
stores accounts for store-operated Ca2+ entry [16]. It was
originally postulated that store-operated Ca2+ entry
function is limited to replenishment of intracellular Ca2+
stores, several observations however provide evidence
for an important role played by these channels in cell
homeostasis or death [17–20]. The significance of capa-
citative Ca2+ entry in the development of apoptosis has
been shown in hamster embryo cells. In this model, a re-
duced store-operated Ca2+ entry correlates with a dys-
regulation of intracellular vesicular traffic and results in
cell death [19]. Capacitative Ca2+ entry is also defective
in immunodeficiency characterized by a lack of lym-
phocytes proliferation [17,21]. In addition, SKF 96365, a
commonly used store-operated Ca2+ channel inhibitor,
is a potent inducer of apoptosis in HL60 cells [20] sug-
gesting that store-operated Ca2+ entry is an important
regulator of the induction and execution phases of apop-
tosis.
We have previously reported that EBV-transformed B
cells from a patient with Scott syndrome show a defective
store-operated Ca2+ entry after stimulation [22], which
enabled further investigation of the link between this
mode of Ca2+ entry and phosphatidylserine transmem-
brane redistribution [23]. Scott patients do not present
other clinical symptoms than bleeding episodes, in par-
ticular (auto)immune disorders have not been observed
[11,12], suggesting that apoptosis and clearance of cell
fragments are normal although procoagulant phosphati-
dylserine exposure is impaired.
Taking advantage of these mutant lymphoblastoid B
cells, in which rapid phosphatidylserine externalization
is considerably reduced following drastic stimulation by
Ca2+ ionophore, but nevertheless able to undergo apop-
tosis over a longer time period [12,14], the present study
is aiming at establishing a relationship between store-
operated Ca2+ entry and phosphatidylserine redistribu-
tion during apoptosis. For this, several agents were used,
Ca2+ ionophore A23187 wich induces Ca2+ release and
entry [24], the Ca2+ channel blocker SKF 96365 [25] and
the cytochrome P450 inhibitor SKF 525A which also in-
hibits store-operated Ca2+ entry in platelets [26]. Inhibi-
tion of store-operated Ca2+ channels by SKF 96365
induces caspase-independent DNA fragmentation and
decrease of mitochondrial membrane potential in both
control and Scott cells, while Ca2+ influx following treat-
ment by Ca2+ ionophore was only protective in control
cells. The dissociation of phosphatidylserine transverse
migration from other intracellular changes indicates the
existence of alternative pathways for the accomplish-
ment of basic functions or responses involving the re-
modeling of the cell plasma membrane.
Results
Apoptosis and store-operated Ca2+ entry
Lymphoblasts were treated for 48 or 72 h with the Ca2+
ionophore A23187 at concentrations of 100, 150 and 200
nM (Figs. 1a and 1b). Control cells showed normal pro-
portions of DNA PI staining, corresponding to normal
2N or 4N DNA content; A23187 even exerted a somewhat
protective effect against basal apoptosis. At the opposite,
in Scott B cells cytometric analysis revealed nuclei with
low DNA staining (sub-G1 peak) corresponding to apop-
totic cells. The percentage of apoptotic nuclei was
A23187 concentration-dependent and at 200 nM, 17.6 ±
2.7 % of the cells have hypodiploid DNA after 72 h. The
apoptotic character of A23187-treated lymphoblasts was
confirmed by TUNEL assay (see below). A reduced capa-
citative Ca2+ entry has been shown to correlate with ap-
optosis [19]. Recently, we have reported that Scott
lymphoblasts show a defective store-operated Ca2+ entry
[22]. Therefore, it was interesting to assess whether inhi-
bition of capacitative Ca2+ channels could induce apop-
tosis in control B lymphoblasts. The experiments were
performed in the presence of 10 µM SKF 96365, a block-
er of store-operated Ca2+ channels [25]. At 10 µM, SKF
96365 reduced by approximately 30 % the level of capa-
citative Ca2+ entry induced by thapsigargin (1 µM) in ei-
ther control or Scott cells (not shown). As shown in Fig.BMC Cell Biology 2001, 2:20 http://www.biomedcentral.com/1471-2121/2/20
1c, the same concentration of SKF 96365, was able to in-
duce apoptosis in both control and Scott cells.
After 48 h, SKF 96365-induced apoptosis in control cells
was significantly higher than in Scott cells (9.6 ± 0.9 %
and 6.6 ± 0.6 % in control and Scott cells, respectively; P
< 0.01), however, after 72 h of treatment, SKF 96365 in-
duced apoptosis at comparable degrees in both types of
cells (12.4 ± 0.8 % and 12.9 ± 2.4 % in control and Scott
cells, respectively). Higher concentrations of SKF 96365
were responsible for necrosis in both types of cells. It
should be noted that when cells were treated with the
combination of Ca2+ ionophore A23187 + SKF 96365,
the degrees of apoptosis were almost additive at 48 h,
and ~40 % higher at 72 h in Scott cells with respect to
values obtained in the presence of A23187 alone, where-
as A23187 remained protective in control lymphoblasts
(Figure 1d).
Some studies have shown that cytochrome P450 activity
is critical with respect to the regulation of store-operated
Ca2+ influx [27,28]. To verify whether cytochrome P450
pathway is implicated in Ca2+ entry induced by depletion
of Ca2+ stores in EBV lymphoblasts, experiments were
also performed in the presence of 10 µM SKF 525A, a cy-
tochrome P450 inhibitor [28]. As observed with SKF
96365, SKF 525A reduced capacitative Ca2+ entry in-
duced by thapsigargin (1 µM) by approximately 30 % in
either control or Scott cells (not shown). In addition, af-
ter 48 or 72 h of treatment, 10 µM SKF 525A induced ap-
optosis at comparable extents in control and Scott cells
(Fig. 2a). When cells were treated with the combination
of Ca2+ ionophore A23187 + SKF 525A, the degrees of
apoptosis in Scott cells were not significantly different
from those observed in the presence of A23187 alone
(Fig. 2b). Again, A23187 exerted a protective effect
Figure 1
Effect of calcium ionophore A23187 and/or calcium channel
inhibitor SKF 96365 on cell death. Control and Scott B lym-
phoblasts were treated with A23187 (100–200 nM) for 48 (a)
or 72 (b) h, or with SKF 96365 (10 µM) for 48 or 72 h in the
absence (c) or in the presence of calcium ionophore A23187
(200 nM) (d). The degree of apoptosis was determined by
measurement of hypodiploid DNA using propidium iodide
(0.1 mg/ml). Values are mean ± SEM of at least 8 independent
determinations. **P < 0.01 versus control cells. †P < 0.05 ver-
sus the corresponding values at 48 h of treatment.
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Figure 2
Effect of the cytochrome P450 inhibitor SKF 525A on cell
death. Control and Scott B lymphoblasts were treated with
SKF 525A (10 µM) for 48 or 72 h in the absence (a) or in the
presence of calcium ionophore A23187 (200 nM) (b). The
degree of apoptosis was determined by measurement of
hypodiploid DNA using propidium iodide (0.1 mg/ml). Values
are mean ± SEM of at least 6 independent determinations. *P
< 0.05 versus control cells.BMC Cell Biology 2001, 2:20 http://www.biomedcentral.com/1471-2121/2/20
against SKF 525A-induced apoptosis in control lym-
phoblasts, more pronounced at 72 h (Fig. 2b).
Experiments using the extracellular Ca2+ chelator EGTA
(1–2 mM) were designed in order to evaluate the rela-
tionship between store-operated Ca2+ entry and apopto-
sis. At 1 mM, EGTA did not induce apoptosis nor affected
Ca2+ ionophore-evoked apoptosis. However, higher con-
centrations of EGTA (1.5 and 2 mM) enhanced cell mor-
tality by necrosis, making measurements of the degree of
apoptosis almost impossible (not shown).
To determine whether caspases are involved in this ap-
optotic process, Ca2+ ionophore- or SKF 96365-treated
cells were incubated in the absence or presence of the
broad-spectrum caspase inhibitor z-VAD.fmk (50 µM) or
the more specific caspase-3 inhibitor, Ac-DEVD-CHO
(50 µM) [29]. Apoptosis analysis, assessed by PI stain-
ing, showed that none of these inhibitors had significant
effect on DNA fragmentation after 48 or 72 h of A23187
treatment of either control or Scott cells (Fig. 3a). How-
ever, z-VAD.fmk interfered in the effect of SKF 96365 on
Scott cells, even exerting an apparent paradoxical poten-
tiation of apoptosis, whereas it did not affect the fate of
control cells to a significant extent (Fig. 3b).
In order to assess the effects of Ca2+ ionophore and
channel blockers on apoptosis, Ca2+ signaling was mon-
itored in viable cells using Fluo-3 fluorochrome and PI to
define a gate excluding necrotic cells, i.e. PI positive cells
representing less than 10 % of the whole population.
Under control condition (Fig. 4), approximately 95 % of
viable cells presented "normal" [Ca2+]i (68 ± 6 and 78 ±
14 fluorescence arbitrary units in control and Scott cells
respectively) and only 3 ± 1 % of cells showed elevated
[Ca2+]i (Table 1). After A23187 (200 nM) treatment, the
latter population with elevated [Ca2+]i was significantly
increased as well as [Ca2+]i itself, but this occurred in
control cells only, and the effect was not inhibited by the
caspase-3 inhibitor Ac-DEVD-CHO (Table 1). In addi-
tion, SKF 96365 did not modify either [Ca2+]i or number
of events in both types of cells. Similar results were ob-
tained with SKF 525A (not shown). However, it should
be noted that when cells were treated with the combina-
tion of Ca2+ ionophore A23187 + SKF 96365, [Ca2+]i was
enhanced in control but not in Scott cells. Furthermore,
in response to UV irradiation, both types of cells under-
went apoptosis as determined by DNA fragmentation but
[Ca2+]i was not modified. For example, at 5 J/cm2, 23 ±
3 % and 28 ± 5 % of the normal and Scott cells had hy-
podiploid DNA, respectively.
DNA fragmentation and mitochondrial membrane potential
A switch from apoptosis to necrosis has been described
in B lymphocytes after incubation in the presence of cas-
pase inhibitor [30]. In order to assess that each of
A23187 or SKF 96365 induces apoptosis and not necro-
sis, TUNEL assay was performed and changes of mito-
Figure 3
Effect of the caspase inhibitors z-VAD.fmk or Ac-DEVD-
CHO on cell death induced by calcium ionophore A23187 or
calcium channel inhibitor SKF 96365. Control and Scott B
lymphoblasts were treated with z-VAD.fmk (50 µM) or Ac-
DEVD-CHO (50 µM) for 48 or 72 h in the presence of cal-
cium ionophore A23187 (200 nM) (a), or in the presence of
the calcium channel inhibitor SKF 96365 (10 µM) (b). The
degree of apoptosis was determined by measurement of
hypodiploid DNA using propidium iodide (0.1 mg/ml). Values
are mean ± SEM of at least 8 independent determinations. *P
< 0.05 versus the corresponding value in the absence of cas-
pase inhibitor.
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chondrial membrane potential were measured by flow
cytometry. Early in apoptosis, TUNEL labeling and mito-
chondrial membrane permeability increase and the mi-
tochondrial inner transmembrane potential decreases
[31]. Fig. 5 shows TUNEL positive staining in SKF
96365-treated cells but not in A23187-treated control
cells, and in both Ca2+ ionophore- and SKF 96365-treat-
ed Scott cells after 48 h, confirming PI results. Similar
observations were made after 72 h treatment (not
shown). While in control cells, A23187 induced a non-
significant decrease of the JC-1 red/green fluorescence
ratio (reflecting ∆ψ ), in Scott cells the effect was more
pronounced, corresponding to higher apoptosis levels
(Table 2). As observed by PI analysis, SKF 96365 treate-
ment induced comparable decreases of the JC-1 red/
green fluorescence ratio in both types of cells after 48 or
72 h treatment (Table 2). z-VAD.fmk treatment limited
the SKF 96365-induced decrease in JC-1 fluorescence af-
ter 48 h treatment, but had no effect on the reduction of
JC-1 fluorescence ratio corresponding to A23187 or SKF
96365 after 72 h treatment.
Phosphatidylserine externalization
Apoptotic cells were assessed for phosphatidylserine ex-
posure by functional procoagulant prothrombinase as-
say, and by annexin V labeling. After Ca2+ ionophore or
SKF 96365 treatment, the degree of phosphatidylserine
externalization remained weak at 48 h and was not af-
fected by the caspase inhibitor z-VAD.fmk (Fig. 6a). At
72 h of A23187 or SKF 96365 treatment, the degree of
phosphatidylserine exposure was enhanced in both types
of cells, and more significantly in SKF 96365-treated
cells (P < 0.05). Phosphatidylserine externalization was
not affected by the caspase inhibitor z-VAD.fmk in con-
trol cells. In Scott cells, z-VAD.fmk however prevented
the phosphatidylserine redistribution induced by Ca2+
ionophore (P < 0.05), but did not reduce the effect of
SKF 96365, even exerting an apparent paradoxical po-
tentiation of phosphatidylserine externalization proba-
bly due to a membrane destabilizing effect when used at
50 µM [32] (Fig. 6b).
In order to compare with more drastic and rapid stimu-
lation, it should be noted that after 10 min of A23187
treatment at 1 µM, prothrombinase activity was en-
hanced in both type of cells, but as previously reported
[12,22] B lymphoblasts from the Scott patient displayed
a ~60 % reduction of prothrombinase activity when com-
pared with control cells (Fig. 6c). Consistent with the
Figure 4
[Ca2+]i determination in control and Scott cells by flow
cytometry. Cells treated for 72 h by 200 nM A23187 or 10
µM SKF 96365 were loaded with the fluorochrome Fluo-3 (3
µM) and propidium iodide (PI, 10 µg/ml). Histograms show
the number of cells as a function of Fluo-3 fluorescence for
the PI negative cell population only. One representative
experiment out of four performed likewise is shown.
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Calcium ionophore and SKF 96365-induced apoptosis of
control and Scott B lymphoblasts, assessed by TUNEL and
flow cytometry. Control and Scott lymphoblasts were
treated with A23187 (200 nM, gray) or SKF 96365 (10 µM,
black) for 48 h, and then stained for DNA fragmentation by
TUNEL as described in the "Experimental Procedures". Fluo-
rescence shifts observed with A23187 or SKF 96365 treat-
ment were compared to those obtained with non-treated
cells (empty). Results were reproduced in at least 3 different
experiments.
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data obtained by the prothrombinase assay at 72 h of
A23187 or SKF 96365 treatment (Fig. 6b) and [Ca2+]i de-
terminations (Fig. 4), the number of annexin V-positive
cells increased in both types of cells (Fig. 7). Moreover,
upon induction of apoptosis by UV irradiation, control
and Scott cells showed approximately the same propor-
tion of annexin V-positive cells (~31 ± 5 % and 34 ± 6 %
of control and Scott cells, respectively). Ac-DEVD-CHO
did not prevent annexin V labeling (not shown), suggest-
ing that phosphatidylserine externalization is independ-
ent of caspase-3 activity.
Discussion
We have previously reported that Scott cells present a
defect of phosphatidylserine externalization in associa-
tion with a reduced store-operated Ca2+ entry after stim-
ulation [22]. In hamster embryo cells, a reduced store-
operated Ca2+ entry correlates with a dysregulation of in-
tracellular vesicular traffic and apoptosis [19]. Here, we
provide direct evidence that impairment of store-operat-
ed Ca2+ entry can causally be implicated in the develop-
ment of apoptosis since Ca2+ influx protects control cells
against apoptosis. In addition, Scott cells are able to ex-
pose phosphatidylserine during apoptosis indicating
that the mechanisms controlling membrane phosphati-
dylserine redistribution during apoptosis and procoagu-
lant response are probably different.
Ca2+ ionophore has been reported to induce Ca2+ release
from intracellular stores, and after sustained depletion,
voltage-independent Ca2+ entry across the plasma mem-
brane [24]. In this study, A23187 treatment induced ap-
optosis only in Scott, but not in control cells, and an
increase in [Ca2+]i only in the latter, indicating that Ca2+
exerts a protective effect against apoptosis. Because Ca2+
release from intracellular stores was similar in Scott and
control cells [22], the present results suggest that re-
duced Ca2+ entry indeed correlates with apoptosis induc-
tion.
In T and B lymphocytes, it has been shown that stimula-
tion of CD95, which leads to apoptosis, blocks store-op-
erated Ca2+ channels and influx through the activation of
acidic sphingomyelinase and ceramide release [33]. In
our study, if capacitative Ca2+ entry is involved in the in-
duction of apoptosis, direct inhibition of this particular
Table 1: Changes of intracellular Ca2+ concentration in the cell population with elevated [Ca2+]i, assessed by flow cytometry using Fluo-
3fluorescence (arbitrary units) in control and Scott cells after 48 or 72 h of apoptosis induction by calcium ionophore A23187 (200 nM) 
or/and SKF 96365 (10 µM), in the absence and presence of the caspase inhibitor Ac-DEVD-CHO (50 µM). Values are the mean ± SEM 
of 4 independent experiments.
CELLS No treatment A23187 (200 nM) SKF 96365 (10 
µM)
A23187 + SKF 
96365
Ac-DEVD-CHO + 
A23187
Control (48 h) 398 ± 25 545 ± 51** 409 ± 17 524 ± 25* 522 ± 23*
Scott (48 h) 371 ± 53 8 2  ± 13 9 0  ± 7 371 ± 14 380 ± 10
Control (72 h) 361 ± 22 470 ± 25* 417 ± 31 490 ± 44* 520 ± 90*
Scott (72 h) 403 ± 62 408 ± 70 376 ± 46 354 ± 54 356 ± 43
*P < 0.05, **P < 0.01 versus the corresponding values obtained with non-treated cells.
Table 2: Changes of mitochondrial membrane potential, assessed by flow cytometry using JC-1 red/green fluorescence ratio in in control 
and Scott cells after 48 or 72 h of apoptosis induction by calcium ionophore A23187 (200 nM) or SKF 96365 (10 µM) in the absence and 
presence of the caspase inhibitor z-VAD.fmk (50 µM). Values are the mean ± SEM of 4 independent experiments.
CELLS No treatment A23187 (200 nM) SKF 96365 (10 
µM)
zVAD + A23187 zVAD + SKF 
96365
Control (48 h) 1.37 ± 0.24 1.05 ± 0.16 0.85 ± 0.11* 1.16 ± 0.03 1.01 ± 0.09
Scott (48 h) 1.25 ± 0.20 1.01 ± 0.17 0.96 ± 0.20* 1.11 ± 0.08 1.20 ± 0.12
Control (72 h) 1.26 ± 0.09 1.1± 0.16 0.89 ± 0.06* 0.97 ± 0.03 0.88 ± 0.04*
Scott (72 h) 1.55 ± 0.12 1.02 ± 0.22* 1.04 ± 0.26* 0.97 ± 0.16* 0.89 ± 0.21*
*P < 0.05 versus the corresponding values obtained with non-treated cells.BMC Cell Biology 2001, 2:20 http://www.biomedcentral.com/1471-2121/2/20
way of Ca2+ entry should trigger apoptosis in cells with a
normal store-operated Ca2+ entry, as observed in other
cells [19,20]. SKF 96365, an inhibitor of store-operated
Ca2+ channels [25], was able to induce apoptosis in both
control and Scott cells in the same proportions. These re-
sults are consistent with the observations of Jayadev et
al. [19] and indicate that after inhibition of store-operat-
ed Ca2+ channels, cells acquire a high propensity to un-
dergo apoptosis. Also, the importance of store-operated
Ca2+ entry in maintaining cell viability has been ob-
served in HL60 cells after induction of apoptosis by SKF
96365 [20]. Here, SKF 96365 did not affect [Ca2+]i in
both cell types, and the data obtained with SKF 525A, an
Figure 6
Procoagulant phosphatidylserine exposure measured by pro-
thrombinase assay after apoptosis induction in control and
Scott cells. Cells were treated for 48 (a) or 72 (b) h, by 200
nM A23187 or 10 µM SKF 96365 in the absence or in the
presence of z-VAD.fmk (50 µM), or for 10 min (c) by 1 µM
A23187, as described in the "Experimental Procedures". Data
are expressed as mean ± SEM of 5 independent experiments
(each with duplicate samples), where  represents the
increase in activity with respect to baseline prothrombinase
activity.  *P < 0.05 versus 72 h A23187 treatment of Scott
cells. §P < 0.05 versus the corresponding value obtained in
the absence of z-VAD.fmk. †P < 0.05 versus the correspond-
ing value obtained with control cells.
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Figure 7
Phosphatidylserine exposure assessed by Annexin V-labeling
after apoptosis induction in control and Scott cells. Cells,
treated for 72 h by 200 nM A23187 or 10 µM SKF 96365,
were loaded with the fluorochrome Fluo-3 (3 µM) and
annexin V-biotin (5 µl at 0.5 mg/ml) and labeling was achieved
with phycoerythrin-conjugated streptavidin. Results are
expressed as phycoerythrin fluorescence versus cell number.
The cell populations with high annexin V labeling correspond
to those with high Fluo-3 fluorescence (Fig. 4). One repre-
sentative experiment out of four performed likewise is
shown.
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inhibitor of cytochrome P450 that also blocks store-op-
erated Ca2+ influx [28], confirm the relationship be-
tween store-operated Ca2+ entry and apoptosis and
suggest that, in B cells, Ca2+ entry is regulated, at least in
part, by the cytochrome P450 enzymatic system.
It has been proposed that Ca2+ release from stores is by
itself sufficient to induce apoptosis [34,35]. Preston et al.
[36] have shown that decreased Ca2+ in endoplasmic re-
ticulum stores due to partial reduction of capacitative
Ca2+ entry leads to poor refilling of these stores and to
apoptosis. In the present study, combinations of SKF
96365 + A23187 or SKF 525A + A23187 resulted in a
weak degree of apoptosis in control cells, which was low-
er than in cells treated with Ca2+ entry inhibitors alone
(i.e. in the absence of A23187). [Ca2+]i measurements
suggest that even when store-operated Ca2+ entry is in-
hibited, A23187-induced Ca2+ influx remains protective
against apoptosis in control cells.
Scott cells show a lack of rapid procoagulant phosphati-
dylserine exposure after drastic ionophore stimulation
[11,12,14]. Here, both control and more markedly Scott
cells externalized phosphatidylserine after induction of
apoptosis, indicating that this process when accounting
for the procoagulant response after a swift elevation of
intracellular Ca2+ depends on a different mechanism
and/or involve different transporters. This does not rule
out that some steps are however common. Our observa-
tions are consistent with those reported in Jurkat [37] or
Raji cells [38], where it has been suggested that phos-
phatidylserine exposure is regulated by multiple path-
ways. Very recently, Williamson et al. [15] have shown
that Scott EBV-lymphoblasts from another patient are
able to externalize phosphatidylserine during apoptosis.
In addition, it is well established that Ca2+ influx is nec-
essary to promote the migration of phosphatidylserine in
the membrane outer leaflet [13]. Then, how phosphati-
dylserine can be externalized in Scott cells if Ca2+ entry
is reduced? One possible explanation is that a ~30% re-
duction of Ca2+ influx is harmless for a normal exposure
of phosphatidylserine during nucleated cell apoptosis,
but not for the rapid exposure of phosphatidylserine by
platelets necessary for the hemostatic response. Phos-
phatidylserine externalization is believed to result from
the inhibition of aminophospholipid translocase and the
activation of Ca2+-dependent outer transport of phos-
pholipids possibly mediated by a nonspecific phospholi-
pid scramblase [15,39,40] or a vectorial transporter such
as ABCA1 [41]. In this respect, phosphatidylserine expo-
sure does not correlate with scramblase expression [38].
Moreover, Scott cells show a normal scramblase expres-
sion [42–44] and, although ABCA1 has been reported to
participate in the transbilayer movement of phosphati-
dylserine [41], the involvement of other transporters
cannot be ruled out [45].
Finally, we have observed a dissociation of membrane
changes of cells undergoing apoptosis from other fea-
tures of programmed death, such as DNA fragmentation
and decrease of mitochondrial ∆ψ . While the latter was
caspase-dependent after 48 h treatment, phosphatidyl-
serine exposure was not. However, after 72 h treatment,
DNA fragmentation and changes of mitochondrial ∆ψ
were caspase-independent in both control and Scott
cells, whereas procoagulant phosphatidylserine expo-
sure induced by A23187, during the same time period,
was inhibited by the caspase inhibitor z-VAD.fmk in
Scott but not in control cells. Nevertheless, a more spe-
cific caspase-3 inhibitor had no effect on DNA fragmen-
tation, [Ca2+]i and phosphatidylserine exposure,
suggesting that caspase-3 pathway is not involved in
these apoptotic features. However, the participation of
other caspases cannot be ruled out. The mechanisms
controlling membrane phosphatidylserine redistribu-
tion during apoptosis are certainly complex, some stud-
ies pointing to the importance of caspase activation
[5,46,47], whereas in other models, caspase are not in-
volved [48,49]. In B cells particularly, apoptotic path-
ways seem to be partitioned into caspase-independent
and caspase-dependent steps, phosphatidylserine expo-
sure following BCR activation being a caspase-depend-
ent process, but not change of ∆ψ  [50]. Also, caspase
inhibition after BCR stimulation blocks DNA fragmenta-
tion but does not prevent cytochrome c release and cell
death [51]. The present results are in favor of alternative
pathways used by Scott cells in order to allow normal vi-
ability, apoptosis and perhaps phagocytosis, which may
explain the absence of other apparent pathogenic conse-
quences of the syndrome.
Conclusions
In summary, inhibition of store-operated Ca2+ channels
induces caspase-independent apoptosis in control and
Scott cells. In the latter, externalization of phosphatidyl-
serine during apoptosis is however dissociated from oth-
er intracellular changes, suggesting a plastic adaptability
of the mechanisms governing phosphatidylserine trans-
membrane redistribution in cells undergoing specialized
stimulation and those entering programmed death.
Materials and Methods
Reagents
X-VIVO 15 medium was from BioWhittaker (Walkers-
ville, MD). PI, type I-A RNAse A and Phycoerythrin-con-
jugated streptavidin were from Sigma Chemical Co. (St
Louis, MO). Ca2+ ionophore A23187, SKF 96365, SKF
525A, z-VAD.fmk and Ac-DEVD-CHO were from Calbio-
chem (La Jolla, CA). Fluo-3/AM and JC-1 were from Mo-BMC Cell Biology 2001, 2:20 http://www.biomedcentral.com/1471-2121/2/20
lecular Probes (Eugene, OR). TUNEL assay kit was from
Roche Diagnostics (Mannheim, Germany). Biotin-la-
beled annexin V has been prepared and characterized as
previously described [52].
Culture of Scott B lymphoblastoid cells
The case of Scott syndrome has been detailed in another
study where homozygous status has been suggested [12].
Lymphocytes were isolated under sterile conditions and
stored in liquid nitrogen. Infection of B lymphocytes by
EBV (EBV B958, Marmouset) was performed in RPMI
culture medium containing 20% FCS in the presence of
50 ng/ml cyclosporin and was achieved within 3 weeks
[12]. Three independent EBV infections could be per-
formed. It should be noted that the Scott phenotype was
observed in these cells after drastic activation with Ca2+
ionophore A23187, as previously described [12,22]. EBV-
infected B cells were expanded in X-VIVO 15 culture me-
dium (free Ca2+ concentration = 1.8 mM).
Induction of apoptosis
The cell viability was checked by Trypan blue exclusion.
Cells were seeded at 5 ×  105 cells/ml in the presence or
absence of A23187 (100–200 nM) for 48 or 72 h. In some
experiments, cells were treated with 10 µM SKF 96365 or
10 µM SKF 525A in the absence or presence of Ca2+ iono-
phore A23187 (200 nM) for 48 or 72 h.
In another set of experiments, cells cultured in a stand-
ard 6-well plate were submitted to UV light by exposure
to the germicidal lamp (peak sensitivity approximately
254 nm) in the tissue culture hood for 10, 20 et 30 s (5,
10 and 15 J/cm2, respectively) and apoptosis was meas-
ured 18 h after irradiation.
Determination of hypodiploid DNA
After the different treatments, cells were harvested and
numbered. Concentration was adjusted to 5 ×  105 cells/
ml of 70% ethanol solution in H2O, and fixation was al-
lowed to proceed during at least 1 h at 4°C. Cells were
washed once in HBSS before resuspension in a solution
containing type I-A RNAse A (0.5 mg/ml) in HBSS and
were incubated for 10 min at 37°C. PI was then added at
a final concentration of 0.1 mg/ml. Samples were al-
lowed to stand another 15 min in the dark at room tem-
perature before flow cytometry analysis using
CELLQuest software (Becton Dickinson, San Jose, CA).
Measurement of [Ca2+]i and phosphatidylserine exposure 
by flow cytometry
Cells (106 cells/ml) were loaded with 3 µM Fluo-3/AM
for 30 min at room temperature. Cells were then washed
twice in X-VIVO 15 medium. Then 10 µg/ml PI was add-
ed in order to determine the proportion of necrotic cells
uptaking PI. Fluo-3 and PI fluorescences were recorded
by flow cytometry. Fluo-3 fluorescence was plotted as
FL-1  versus PI fluorescence as FL-2, and both were
measured in fluorescence arbitrary intensity units.
In another set of experiments, phosphatidylserine exter-
nalization was assessed by monitoring annexin V-biotin
binding, simultaneously with [Ca2+]i measurement in vi-
able cells only, i.e. in those excluding PI. Briefly, cells
were loaded with fluo-3 as described above. After 20 min
of Fluo-3 loading, 5 µl of annexin V-biotin at 0.5 mg/ml
was added. After 10 min of incubation in the dark, at
room temperature, cells were washed by one centrifuga-
tion-resuspension step in X-VIVO 15 medium. Labeling
was achieved following another 10 min incubation at
room temperature with phycoerythrin-conjugated
streptavidin. Cells were washed by a centrifugation-re-
suspension step with X-VIVO 15.
Terminal deoxynucleotidyl transferase fluorescein-dUTP 
nick end labeling (TUNEL) assay
To assess the occurrence of A23187- or SKF 96365-in-
duced apoptosis in B cells, labeling of fragmented DNA
was performed by TUNEL assay using a commercially
available cell death detection kit according to the manu-
facturer's instruction. In brief, cells were fixed with 4%
paraformaldehyde solution for 20 min at 4°C and then
washed with PBS. Endogenous peroxidases were inacti-
vated by 0.3% H2O2 in a 70% methanol solution for 20
min, then cells were washed with PBS and incubated
with permeabilization solution (0.1% Triton X-100) for 2
min at 4°C. Apoptotic cells were incubated with 50 µl of
TUNEL reaction mixture for 80 min at 37 °C. After sub-
strate addition, stained cells were analyzed by flow cy-
tometry. Negative control samples for TUNEL staining
lacked terminal deoxynucleotidyl transferase.
Determination of mitochondrial membrane potential (∆ψ )
∆ψ  was determined by monitoring the decrease in red
fluorescence and the increase in green fluorescence by
flow cytometry after labeling the cells with JC-1. Cells
suspensions were ajusted to a density of 5 ×  105 cells/ml
and incubated in complete medium with JC-1 (1 µg/ml)
for 15 min at room temperature in the dark. At the end of
the incubation period, the cells were washed twice in
PBS. For each experiment, A23187 or SKF 96365-treated
and control cells were analyzed for both red and green
fluorescences after JC-1 labeling. The mean fluorescence
ratio was calculated from the mean red and green fluo-
rescence for the entire sample population [53].
Functional detection of procoagulant phosphatidylserine
Procoagulant phospholipid exposure in apoptotic cells
was detected using a human prothrombinase assay in
which phosphatidylserine promotes the activation of
prothrombin by factor Xa in the presence of factor VaBMC Cell Biology 2001, 2:20 http://www.biomedcentral.com/1471-2121/2/20
[54]. Thrombin generated by assembled prothrombinase
complex was measured using a chromogenic assay as de-
scribed elsewhere [12]. EBV-infected B lymphocytes
were studied at 2 ×  105 cells/ml and the ability to exter-
nalize procoagulant phosphatidylserine was examined
after treatment by A23187 (200 nM) or SKF 96365 (10
µM) in the absence or presence of z-VAD.fmk (50 µM)
during 48 and 72 h, or 10 min only in case of more drastic
stimulation by 1 µM A23187. The cells were separated
from derived membrane microparticles by centrifuga-
tion at 12,000 g for 1 min before measurement. For each
protocol, results were compared with the prothrombi-
nase activity developed in samples from healthy volun-
teers. Linear absorbance changes were converted to
concentration of generated thrombin by reference to a
standard curve. Prothrombinase activity was normalized
to 2 ×  105 cells/ml and was expressed as the increase in
activity () with respect to baseline prothrombinase ac-
tivity of untreated cells.
Statistical analysis
Experiments were performed at different culture stages.
Unpaired Student's t-test was used for the statistical
analysis. A P < 0.05 value was considered significant.
Abbreviations
Ac-DEVD-CHO, Ac-Asp-Glu-Val-Asp-CHO; BCR, B cell
receptor; Fluo-3/AM, fluo-3/acetocymethyl ester; JC-1,
5,5',6,6'-tetrachloro-1,1'3,3'-tetraethyl-benzimidazolcar-
bocyanine iodide; PI, propidium iodide; SKF 525A, α -
phenyl-α -propylbenzeneacetic acid 2-[diethylami-
no]ethyl ester; SKF 96365, 1-[β -[3-(4-methoxyphe-
nyl)propoxy]-4-methoxyphenethyl]-1H-imidazole;
TUNEL, Terminal deoxynucleotidyl transferase fluores-
cein-dUTP nick end labeling; z-VAD.fmk, z-Val-Ala-
Asp.fluoromethyl ketone.
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